Flow Traders U.S.’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Flow Traders U.S.’s Portfolio BIS Stock Details BIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13	Closed	-$3K	–	504
2016 Q3	$3K	Buy	+13	New	+$3.45K	﹤0.01%	370
2014 Q4	–	Sell	-2,220	Closed	-$1.07M	–	185
2014 Q3	$1.07M	Buy	2,220 +2,167	+4,089%	+$1.15M	0.13%	53
2014 Q2	$30K	Buy	+53	New	+$36.5K	0.01%	137

Other funds holding BIS

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Flow Traders U.S.'s BIS Position: Q4 2016 in Review

Flow Traders U.S. sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q4 2016, closing a stake of 13 shares — an estimated $3K sold.

Flow Traders U.S. first reported a position in BIS in Q2 2014 and held it in 3 quarters. The position peaked at $1.07M in Q3 2014. 13 funds tracked by Wall St. Rank hold BIS as of Q4 2016.

Flow Traders U.S. reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q4 2016 after selling out during the quarter.
Flow Traders U.S. sold 13 ProShares UltraShort NASDAQ Biotechnology shares in Q4 2016, an estimated $3K.
Flow Traders U.S. first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2014 and held it in 3 quarters.
Flow Traders U.S.'s ProShares UltraShort NASDAQ Biotechnology position peaked at $1.07M in Q3 2014.
13 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q4 2016.

Based on Flow Traders U.S.'s 13F filing for Q4 2016, filed 14 Feb 2017.